Sale!

MYO1E Gene Focal Segmental Glomerulosclerosis Type 6 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The MYO1E Gene Focal Segmental Glomerulosclerosis Type 6 Genetic Test is a specialized diagnostic examination offered by DNA Labs UAE, designed to identify mutations in the MYO1E gene, which are linked to the development of Focal Segmental Glomerulosclerosis (FSGS) Type 6. FSGS is a disease that affects the kidney’s filtering units, leading to serious conditions such as nephrotic syndrome and, ultimately, kidney failure. The identification of a mutation in the MYO1E gene through this test can provide crucial information for the diagnosis, prognosis, and personalized treatment planning for affected individuals. The test, priced at 4400 AED, involves analyzing the patient’s DNA to detect any genetic anomalies associated with this condition, thereby offering a targeted approach to understanding and managing this specific type of FSGS. By opting for this genetic test at DNA Labs UAE, patients and healthcare providers can gain valuable insights into the genetic underpinnings of FSGS Type 6, facilitating early intervention and tailored therapeutic strategies.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

MYO1E Gene Focal Segmental Glomerulosclerosis Type 6 Genetic Test

At DNA Labs UAE, we offer the MYO1E Gene Focal Segmental Glomerulosclerosis Type 6 Genetic Test. This test is designed to diagnose and provide important information for the medical management and treatment of individuals with FSGS type 6, a rare genetic disorder affecting the kidneys.

Test Details

The MYO1E gene is associated with focal segmental glomerulosclerosis (FSGS) type 6, a kidney disease characterized by scarring of the glomeruli. This scarring leads to excessive protein in the urine (proteinuria) and can eventually progress to kidney failure.

Our NGS (Next-Generation Sequencing) technology allows us to analyze multiple genes simultaneously, including the MYO1E gene. By identifying specific genetic variations in the MYO1E gene, our NGS testing can help diagnose individuals with FSGS type 6 and provide important information for their medical management and treatment.

In addition to diagnosis, our genetic test can also be used for genetic counseling and to assess the risk of passing the condition on to future generations.

Test Components and Price

  • Test Name: MYO1E Gene Focal Segmental Glomerulosclerosis Type 6 Genetic Test
  • Components: NGS Technology
  • Price: 4400.0 AED

Sample Condition

We accept the following sample conditions:

  • Blood
  • Extracted DNA
  • One drop Blood on FTA Card

Report Delivery

Your test report will be delivered within 3 to 4 weeks.

Referring Doctor

We recommend consulting with a General Physician for the MYO1E Gene Focal Segmental Glomerulosclerosis Type 6 Genetic Test.

Test Department

The MYO1E Gene Focal Segmental Glomerulosclerosis Type 6 Genetic Test is conducted in our Genetics department.

Pre Test Information

Prior to the test, it is important to provide the clinical history of the patient who is going for the MYO1E Gene Focal Segmental Glomerulosclerosis Type 6 NGS Genetic DNA Test. A genetic counseling session will be conducted to draw a pedigree chart of family members affected with the MYO1E Gene.

If you suspect you or someone you know may have FSGS type 6, we recommend consulting with a healthcare provider or genetic counselor for further evaluation and testing.

Test Name MYO1E Gene Focal segmental glomerulosclerosis type 6 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Hepatology Nephrology Endocrinology Disorders
Doctor General Physician
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for MYO1E Gene Focal segmental glomerulosclerosis type 6 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MYO1E Gene Focal segmental glomerulosclerosis type 6 NGS Genetic DNA Test gene MYO1E
Test Details

The MYO1E gene is associated with focal segmental glomerulosclerosis (FSGS) type 6, which is a rare genetic disorder affecting the kidneys. FSGS is a kidney disease characterized by scarring of the glomeruli, the filtering units of the kidneys. This scarring leads to proteinuria (excessive protein in the urine) and can eventually progress to kidney failure.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of FSGS type 6, NGS genetic testing can be used to identify mutations or variations in the MYO1E gene that may be responsible for the development of the disease.

By identifying specific genetic variations in the MYO1E gene, NGS testing can help diagnose individuals with FSGS type 6 and provide important information for their medical management and treatment. It can also be used for genetic counseling and to assess the risk of passing the condition on to future generations.

It’s important to note that NGS testing is typically performed by healthcare professionals who specialize in genetic testing and interpretation. If you suspect you or someone you know may have FSGS type 6, it is recommended to consult with a healthcare provider or genetic counselor for further evaluation and testing.